4
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome

, , , , &
Pages 189-195 | Published online: 03 Aug 2009

  • Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–61.
  • Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774–800.
  • Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078–82.
  • Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897–9.
  • Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434–8.
  • Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322–53.
  • Atiomo WU, Pearson S, Shaw S, Prentice A, Dubbins P. Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS). Ultrasound Med Biol 2000; 26: 977–80.
  • Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome – a hypothesis. J Endocrinol 2002; 174: 1–5.
  • Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003; 24: 302–12.
  • Battaglia C, Artini PG, D’Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in thediagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995; 172: 108–13.
  • Battaglia C, Artini PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S, et al. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 1996; 7: 342–6.
  • Aleem FA, Predanic M. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril 1996; 65: 510–6.
  • Battaglia C, Artini PG, Genazzani AD, Gremigni R, Salvatori M, Sgherzi MR, et al. Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome. Gynecol Endocrinol 1997; 11: 105–10.
  • Lees C, Jurkovic D, Zaidi J, Campbell S. Unexpected effect of a nitric oxide donor on uterine artery Doppler velocimetry in oligomenorrheic women with polycystic ovaries. Ultrasound Obstet Gynecol 1998; 11: 129–32.
  • Zaidi J. Blood flow changes in the ovarian and uterine arteries in women with normal and polycystic ovaries. Hum Fertil (Camb) 2000; 3: 194–8.
  • Ajossa S, Guerriero S, Paoletti AM, Orru M, Floris S, Mannias M, et al. Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome. J Assist Reprod Genet 2001; 18:436–40.
  • Resende AV, Mendes MC, Dias de Moura M, Mendonca HC, Gome Premoli AC, Reis RM, et al. Doppler study of the uterine arteries and ovarian stroma in patients with polycystic ovary syndrome. Gynecol Obstet Invest 2001; 52: 153–7.
  • Ajossa S, Guerriero S, Paoletti AM, Orru M, Melis GB. Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome. Ultrasound Obstet Gynecol 2002; 2: 276–80.
  • Zaidi J, Jacobs H, Campbell S, Tan SL. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations. Ultrasound Obstet Gynecol 1998; 12: 188–96.
  • Doldi N, Gessi A, Destefani A, Calzi F, Ferrari A. Polycystic ovary syndrome: anomalies in progesterone production. Hum Reprod 1998; 13: 290–3.
  • Glueck CJ, Awadalla SG, Phillips H, Cameron D, Wang P, Fontaine RN. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Metabolism 1999; 48: 1589–95.
  • Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001; 16: 2606–9.
  • Diejomaoh M, Jirous J, Al-Azemi M, Baig S, Gupta M, Tallat A. The relationship of recurrent spontaneous miscarriage with reproductive failure. Med Princ Pract 2003; 12: 107–11.
  • Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 2002; 17: 190–4.
  • Nakatsuka M, Habara T, Noguchi S, Konishi H, Kudo T. Increased plasma adrenomedullin in women with recurrent pregnancy loss. Obstet Gynecol 2003; 102: 319–24.
  • Nakatsuka M, Habara T, Noguchi S, Konishi H, Kudo T. Impaired uterine arterial blood flow in pregnant women with recurrent pregnancy loss. J Ultrasound Med 2003; 22: 27–31.
  • Nakatsuka M, Asagiri K, Noguchi S, Habara T, Kudo T. Nafamostat mesylate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. Life Sci 2000; 67: 1243–50.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9.
  • Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003; 163: 1549–54.
  • Panagiotakos DB, Pitsavos C, Skoumas J, Chrysohoou C, Toutouza M, Stefanadis CI, et al. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987–2002). Curr Med Res Opin 2003; 19: 89–94.
  • Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003; 24: 183–217.
  • Shinozaki K, Kashiwagi A, Masada M, Okamura T. Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state. J Pharmacol Sci 2003; 91: 187–91.
  • Giltay EJ, Lambert J, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women. Diabetologia 1999; 42: 214–21.
  • Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson SK Jr. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 1996; 174: 1224–9; discussion 1229–32.
  • Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000; 20: 2414–21.
  • Lakhani K, Seifalian AM, Hardiman P. Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 2002; 106: 81–5.
  • Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 742–6.
  • Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 1851–6.
  • Tuckerman EM, Okon MA, Li T, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 2000; 74: 771–9.
  • Goswamy RK, Steptoe PC. Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Hum Reprod 1988; 3: 721–6.
  • Nakatsuka M, Tada K, Kimura Y, Asagiri K, Kamada Y, Takata M, et al. Clinical experience of long-term transdermal treatment with nitric oxide donor for women with preeclampsia. Gynecol Obstet Invest 1999; 47: 13–9.
  • Nakatsuka M, Takata M, Tada K, Asagiri K, Habara T, Noguchi S, et al. A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002; 21: 831–6.
  • Takata M, Nakatsuka M, Kudo T. Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women. Obstet Gynecol 2002; 100: 931–9.
  • de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998; 76: 91–5.
  • Kashyap S, Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 2000; 45: 991–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.